Patents Assigned to Karopharm Therapeutics Inc.
  • Nuclear transport modulators and uses thereof
    Patent number: 10709706
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula (I) or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: July 14, 2020
    Assignee: Karopharm Therapeutics Inc.
    Inventor: Erkan Baloglu